Russell Investments Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.39M | Sell |
|
|||||
|
2025
Q2 | $3.94M | Buy |
|
|||||
|
2025
Q1 | $775K | Buy |
|
|||||
|
2024
Q4 | $210K | Buy |
|
|||||
|
2024
Q3 | $114K | Sell |
|
|||||
|
2024
Q2 | $515K | Buy |
|
|||||
|
2024
Q1 | $298K | Buy |
|
|||||
|
2023
Q4 | $117K | Sell |
|
|||||
|
2023
Q3 | $147K | Sell |
|
|||||
|
2023
Q2 | $343K | Sell |
|
|||||
|
2023
Q1 | $1.44M | Buy |
|
|||||
|
2022
Q4 | $1.73M | Buy |
|
|||||
|
2022
Q3 | $1.6M | Sell |
|
|||||
|
2022
Q2 | $2.62M | Buy |
|
|||||
|
2022
Q1 | $1.31M | Buy |
|
|||||
|
2021
Q4 | $28K | Hold |
|
|||||
|
2021
Q3 | $29K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $323K | Sell |
|
|||||
|
2019
Q4 | $1.15M | Buy |
|
|||||
|
2019
Q3 | $466K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $74K | Sell |
|
|||||
|
2017
Q1 | $417K | Buy |
|
|||||
|
2016
Q4 | $104K | Buy |
|